Moreover, it has also been shown that IL-6 reduces endothelial nitric oxide production and adiponectin expression, thus suggesting the role of IL-6 also in patients with chronic kidney disease by inducing chronic vascular disease. Here, ADIPOQ is linked to chronic kidney disease.